233 related articles for article (PubMed ID: 23512607)
41. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids.
Navab M; Berliner JA; Subbanagounder G; Hama S; Lusis AJ; Castellani LW; Reddy S; Shih D; Shi W; Watson AD; Van Lenten BJ; Vora D; Fogelman AM
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):481-8. PubMed ID: 11304461
[TBL] [Abstract][Full Text] [Related]
42. Dual signaling evoked by oxidized LDLs in vascular cells.
Nègre-Salvayre A; Augé N; Camaré C; Bacchetti T; Ferretti G; Salvayre R
Free Radic Biol Med; 2017 May; 106():118-133. PubMed ID: 28189852
[TBL] [Abstract][Full Text] [Related]
43. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage.
Bochkov VN; Kadl A; Huber J; Gruber F; Binder BR; Leitinger N
Nature; 2002 Sep; 419(6902):77-81. PubMed ID: 12214235
[TBL] [Abstract][Full Text] [Related]
44. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
Romeo GR; Moulton KS; Kazlauskas A
Circ Res; 2007 Aug; 101(4):357-67. PubMed ID: 17615372
[TBL] [Abstract][Full Text] [Related]
45. Molecular chaperones and heat shock proteins in atherosclerosis.
Xu Q; Metzler B; Jahangiri M; Mandal K
Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H506-14. PubMed ID: 22058161
[TBL] [Abstract][Full Text] [Related]
46. New families of bioactive oxidized phospholipids generated by immune cells: identification and signaling actions.
O'Donnell VB; Murphy RC
Blood; 2012 Sep; 120(10):1985-92. PubMed ID: 22802337
[TBL] [Abstract][Full Text] [Related]
47. Oxidized phospholipids regulate expression of ATF4 and VEGF in endothelial cells via NRF2-dependent mechanism: novel point of convergence between electrophilic and unfolded protein stress pathways.
Afonyushkin T; Oskolkova OV; Philippova M; Resink TJ; Erne P; Binder BR; Bochkov VN
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1007-13. PubMed ID: 20185790
[TBL] [Abstract][Full Text] [Related]
48. Identification of a novel series of anti-inflammatory and anti-oxidative phospholipid oxidation products containing the cyclopentenone moiety
Lu J; Guo S; Xue X; Chen Q; Ge J; Zhuo Y; Zhong H; Chen B; Zhao M; Han W; Suzuki T; Zhu M; Xia L; Schneider C; Blackwell TS; Porter NA; Zheng L; Tsimikas S; Yin H
J Biol Chem; 2017 Mar; 292(13):5378-5391. PubMed ID: 28202546
[TBL] [Abstract][Full Text] [Related]
49. Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration.
Cherepanova OA; Pidkovka NA; Sarmento OF; Yoshida T; Gan Q; Adiguzel E; Bendeck MP; Berliner J; Leitinger N; Owens GK
Circ Res; 2009 Mar; 104(5):609-18. PubMed ID: 19168440
[TBL] [Abstract][Full Text] [Related]
50. Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.
Capra V; Bäck M; Barbieri SS; Camera M; Tremoli E; Rovati GE
Med Res Rev; 2013 Mar; 33(2):364-438. PubMed ID: 22434418
[TBL] [Abstract][Full Text] [Related]
51. The Biosynthesis of Enzymatically Oxidized Lipids.
Hajeyah AA; Griffiths WJ; Wang Y; Finch AJ; O'Donnell VB
Front Endocrinol (Lausanne); 2020; 11():591819. PubMed ID: 33329396
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of monocyte chemotaxis by VB-201, a small molecule lecinoxoid, hinders atherosclerosis development in ApoE⁻/⁻ mice.
Feige E; Yacov N; Salem Y; Levi I; Mendel I; Propheta-Meiran O; Shoham A; Hait-Darshan R; Polonsky O; George J; Harats D; Breitbart E
Atherosclerosis; 2013 Aug; 229(2):430-9. PubMed ID: 23880199
[TBL] [Abstract][Full Text] [Related]
53. Inflammation, Lipid (Per)oxidation, and Redox Regulation.
Dias IHK; Milic I; Heiss C; Ademowo OS; Polidori MC; Devitt A; Griffiths HR
Antioxid Redox Signal; 2020 Jul; 33(3):166-190. PubMed ID: 31989835
[No Abstract] [Full Text] [Related]
54. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity.
Miller YI; Choi SH; Wiesner P; Fang L; Harkewicz R; Hartvigsen K; Boullier A; Gonen A; Diehl CJ; Que X; Montano E; Shaw PX; Tsimikas S; Binder CJ; Witztum JL
Circ Res; 2011 Jan; 108(2):235-48. PubMed ID: 21252151
[TBL] [Abstract][Full Text] [Related]
55. Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a).
Leibundgut G; Scipione C; Yin H; Schneider M; Boffa MB; Green S; Yang X; Dennis E; Witztum JL; Koschinsky ML; Tsimikas S
J Lipid Res; 2013 Oct; 54(10):2815-30. PubMed ID: 23828779
[TBL] [Abstract][Full Text] [Related]
56. Reactive oxygen species in pathogenesis of atherosclerosis.
Goncharov NV; Avdonin PV; Nadeev AD; Zharkikh IL; Jenkins RO
Curr Pharm Des; 2015; 21(9):1134-46. PubMed ID: 25312724
[TBL] [Abstract][Full Text] [Related]
57. Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions.
Bochkov VN; Philippova M; Oskolkova O; Kadl A; Furnkranz A; Karabeg E; Afonyushkin T; Gruber F; Breuss J; Minchenko A; Mechtcheriakova D; Hohensinner P; Rychli K; Wojta J; Resink T; Erne P; Binder BR; Leitinger N
Circ Res; 2006 Oct; 99(8):900-8. PubMed ID: 16973904
[TBL] [Abstract][Full Text] [Related]
58. Oxidized phospholipids in Doxorubicin-induced cardiotoxicity.
Koleini N; Nickel BE; Edel AL; Fandrich RR; Ravandi A; Kardami E
Chem Biol Interact; 2019 Apr; 303():35-39. PubMed ID: 30707978
[TBL] [Abstract][Full Text] [Related]
59. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators.
Merched AJ; Ko K; Gotlinger KH; Serhan CN; Chan L
FASEB J; 2008 Oct; 22(10):3595-606. PubMed ID: 18559988
[TBL] [Abstract][Full Text] [Related]
60. Novel therapeutic strategies targeting vascular redox in human atherosclerosis.
Antonopoulos AS; Antoniades C; Tousoulis D; Bakogiannis C; Demosthenous M; Psarros C; Stefanadis C
Recent Pat Cardiovasc Drug Discov; 2009 Jun; 4(2):76-87. PubMed ID: 19519550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
